| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |



From the Laboratory of Immunobiology,*
the Intramural
Research Support Program,
Science Applications
International Corporation, Frederick, Maryland; the Molecular Aspects
of Drug Design Section,§
National Cancer
Institute, Frederick Cancer Research and Development Center, Frederick,
Maryland; the Surgical Neurology Branch,¶
National
Institute of Neurological Disorders and Stroke, National Institutes of
Health, Bethesda, Maryland; the Department of Microbiology and
Molecular Genetics,
College of Medicine,
University of California at Irvine, Irvine, California; the St. Louis
University School of Medicine,**
St. Louis,
Missouri; and the Academy of Sciences,||
Prague,
Czech Republic
An acidic extracellular pH is a fundamental property of the malignant phenotype. In von Hippel-Lindau (VHL)-defective tumors the cell surface transmembrane carbonic anhydrase (CA) CA9 and CA12 genes are overexpressed because of the absence of pVHL. We hypothesized that these enzymes might be involved in maintaining the extracellular acidic pH in tumors, thereby providing a conducive environment for tumor growth and spread. Using Northern blot analysis and immunostaining with specific antibodies we analyzed the expression of CA9 and CA12 genes and their products in a large sample of cancer cell lines, fresh and archival tumor specimens, and normal human tissues. Expression was also analyzed in cultured cells under hypoxic conditions. Expression of CA IX and CA XII in normal adult tissues was detected only in highly specialized cells and for most tissues their expression did not overlap. Analysis of RNA samples isolated from 87 cancer cell lines and 18 tumors revealed high-to-moderate levels of expression of CA9 and CA12 in multiple cancers. Immunohistochemistry revealed high-to-moderate expression of these enzymes in various normal tissues and multiple common epithelial tumor types. The immunostaining was seen predominantly on the cell surface membrane. The expression of both genes was markedly induced under hypoxic conditions in tumors and cultured tumor cells. We conclude that the cell surface trans-membrane carbonic anhydrases CA IX and CA XII are overexpressed in many tumors suggesting that this is a common feature of cancer cells that may be required for tumor progression. These enzymes may contribute to the tumor microenvironment by maintaining extracellular acidic pH and helping cancer cells grow and metastasize. Our studies show an important causal link between hypoxia, extracellular acidification, and induction or enhanced expression of these enzymes in human tumors.
This article has been cited by other articles:
![]() |
T. Narita, S. Yin, C. F. Gelin, C. S. Moreno, M. Yepes, K.C. Nicolaou, and E. G. Van Meir Identification of a Novel Small Molecule HIF-1{alpha} Translation Inhibitor Clin. Cancer Res., October 1, 2009; 15(19): 6128 - 6136. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chiche, K. Ilc, J. Laferriere, E. Trottier, F. Dayan, N. M. Mazure, M. C. Brahimi-Horn, and J. Pouyssegur Hypoxia-Inducible Carbonic Anhydrase IX and XII Promote Tumor Cell Growth by Counteracting Acidosis through the Regulation of the Intracellular pH Cancer Res., January 1, 2009; 69(1): 358 - 368. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Esbaugh, S. F. Perry, and K. M. Gilmour Hypoxia-inducible carbonic anhydrase IX expression is insufficient to alleviate intracellular metabolic acidosis in the muscle of zebrafish, Danio rerio Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2009; 296(1): R150 - R160. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y Akiba, M Mizumori, M Kuo, M Ham, P H Guth, E Engel, and J D Kaunitz CO2 chemosensing in rat oesophagus Gut, December 1, 2008; 57(12): 1654 - 1664. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Greiner, L. Bullinger, B.-a. Guinn, H. Dohner, and M. Schmitt Leukemia-Associated Antigens Are Critical for the Proliferation of Acute Myeloid Leukemia Cells Clin. Cancer Res., November 15, 2008; 14(22): 7161 - 7166. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Guimbellot, J. A. Fortenberry, G. P. Siegal, B. Moore, H. Wen, C. Venglarik, Y.-F. Chen, S. Oparil, E. J. Sorscher, and J. S. Hong Role of Oxygen Availability in CFTR Expression and Function Am. J. Respir. Cell Mol. Biol., November 1, 2008; 39(5): 514 - 521. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Brouwers, P. F.A. Mulders, and W. J.G. Oyen Carbonic Anhydrase IX Expression in Clear Cell Renal Cell Carcinoma and Normal Tissues: Experiences From (Radio) Immunotherapy J. Clin. Oncol., August 1, 2008; 26(22): 3808 - 3809. [Full Text] [PDF] |
||||
![]() |
B. C. Leibovich, Y. Sheinin, C. M. Lohse, R. H. Thompson, J. C. Cheville, J. Zavada, and E. D. Kwon In Reply J. Clin. Oncol., August 1, 2008; 26(22): 3811 - 3812. [Full Text] [PDF] |
||||
![]() |
K. Salnikow, O. Aprelikova, S. Ivanov, S. Tackett, M. Kaczmarek, A. Karaczyn, H. Yee, K. S. Kasprzak, and J. Niederhuber Regulation of hypoxia-inducible genes by ETS1 transcription factor Carcinogenesis, August 1, 2008; 29(8): 1493 - 1499. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Swietach, S. Wigfield, P. Cobden, C. T. Supuran, A. L. Harris, and R. D. Vaughan-Jones Tumor-associated Carbonic Anhydrase 9 Spatially Coordinates Intracellular pH in Three-dimensional Multicellular Growths J. Biol. Chem., July 18, 2008; 283(29): 20473 - 20483. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Barnett, S. Sheng, T. Howe Charn, A. Waheed, W. S. Sly, C.-Y. Lin, E. T. Liu, and B. S. Katzenellenbogen Estrogen Receptor Regulation of Carbonic Anhydrase XII through a Distal Enhancer in Breast Cancer Cancer Res., May 1, 2008; 68(9): 3505 - 3515. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Haapasalo, M. Hilvo, K. Nordfors, H. Haapasalo, S. Parkkila, A. Hyrskyluoto, I. Rantala, A. Waheed, W. S. Sly, S. Pastorekova, et al. Identification of an alternatively spliced isoform of carbonic anhydrase XII in diffusely infiltrating astrocytic gliomas Neuro Oncology, April 1, 2008; 10(2): 131 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Kim, H. J. Shin, K.-Y. Jung, S.-K. Baek, B. K. Shin, J. Choi, B. S. Kim, S. W. Shin, Y. H. Kim, J. S. Kim, et al. Prognostic Value of Carbonic Anhydrase IX and Ki-67 Expression in Squamous Cell Carcinoma of the Tongue Jpn. J. Clin. Oncol., November 1, 2007; 37(11): 812 - 819. [Abstract] [Full Text] [PDF] |
||||
![]() |
C B Westbury, A Pearson, A Nerurkar, J S Reis-Filho, D Steele, C Peckitt, G Sharp, and J R Yarnold Hypoxia can be detected in irradiated normal human tissue: a study using the hypoxic marker pimonidazole hydrochloride Br. J. Radiol., November 1, 2007; 80(959): 934 - 938. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Leibovich, Y. Sheinin, C. M. Lohse, R. H. Thompson, J. C. Cheville, J. Zavada, and E. D. Kwon Carbonic Anhydrase IX Is Not an Independent Predictor of Outcome for Patients With Clear Cell Renal Cell Carcinoma J. Clin. Oncol., October 20, 2007; 25(30): 4757 - 4764. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Niemela, P. Hynninen, J.-P. Mecklin, T. Kuopio, A. Kokko, L. Aaltonen, A.-K. Parkkila, S. Pastorekova, J. Pastorek, A. Waheed, et al. Carbonic Anhydrase IX Is Highly Expressed in Hereditary Nonpolyposis Colorectal Cancer Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1760 - 1766. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Wendler, S. Amatya, C. McClaskey, S. Ghatpande, B. B. Fredholm, and S. A. Rivkees A1 adenosine receptors play an essential role in protecting the embryo against hypoxia PNAS, June 5, 2007; 104(23): 9697 - 9702. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Scheibe, G. Gros, S. Parkkila, A. Waheed, J. H. Grubb, G. N. Shah, W. S. Sly, and P. Wetzel Expression of Membrane-bound Carbonic Anhydrases IV, IX, and XIV in the Mouse Heart J. Histochem. Cytochem., December 1, 2006; 54(12): 1379 - 1391. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kaluz, M. Kaluzova, and E. J. Stanbridge Proteasomal Inhibition Attenuates Transcriptional Activity of Hypoxia-Inducible Factor 1 (HIF-1) via Specific Effect on the HIF-1{alpha} C-Terminal Activation Domain Mol. Cell. Biol., August 1, 2006; 26(15): 5895 - 5907. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Schoffski, H. Dumez, P. Clement, A. Hoeben, H. Prenen, P. Wolter, S. Joniau, T. Roskams, and H. Van Poppel Emerging role of tyrosine kinase inhibitors in the treatment of advanced renal cell cancer: a review Ann. Onc., August 1, 2006; 17(8): 1185 - 1196. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Grosch, T. J. Maier, S. Schiffmann, and G. Geisslinger Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors. J Natl Cancer Inst, June 7, 2006; 98(11): 736 - 747. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Dayan, D. Roux, M. C. Brahimi-Horn, J. Pouyssegur, and N. M. Mazure The Oxygen Sensor Factor-Inhibiting Hypoxia-Inducible Factor-1 Controls Expression of Distinct Genes through the Bifunctional Transcriptional Character of Hypoxia-Inducible Factor-1{alpha}. Cancer Res., April 1, 2006; 66(7): 3688 - 3698. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pan, M. Leppilampi, S. Pastorekova, J. Pastorek, A. Waheed, W. S. Sly, and S. Parkkila Carbonic anhydrase gene expression in CA II-deficient (Car2-/-) and CA IX-deficient (Car9-/-) mice J. Physiol., March 1, 2006; 571(2): 319 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Cairns, I. Papandreou, and N. Denko Overcoming Physiologic Barriers to Cancer Treatment by Molecularly Targeting the Tumor Microenvironment Mol. Cancer Res., February 1, 2006; 4(2): 61 - 70. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Haapasalo, K. M. Nordfors, M. Hilvo, I. J. Rantala, Y. Soini, A.-K. Parkkila, S. Pastorekova, J. Pastorek, S. M. Parkkila, and H. K. Haapasalo Expression of Carbonic Anhydrase IX in Astrocytic Tumors Predicts Poor Prognosis Clin. Cancer Res., January 15, 2006; 12(2): 473 - 477. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mayer, M. Hockel, and P. Vaupel Carbonic Anhydrase IX Expression and Tumor Oxygenation Status Do Not Correlate at the Microregional Level in Locally Advanced Cancers of the Uterine Cervix Clin. Cancer Res., October 15, 2005; 11(20): 7220 - 7225. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Proescholdt, C. Mayer, M. Kubitza, T. Schubert, S.-Y. Liao, E. J. Stanbridge, S. Ivanov, E. H. Oldfield, A. Brawanski, and M. J. Merrill Expression of hypoxia-inducible carbonic anhydrases in brain tumors Neuro Oncology, October 1, 2005; 7(4): 465 - 475. [Abstract] [PDF] |
||||
![]() |
A Ivanova, S-Y Liao, M I Lerman, S Ivanov, and E J Stanbridge STRA13 expression and subcellular localisation in normal and tumour tissues: implications for use as a diagnostic and differentiation marker J. Med. Genet., July 1, 2005; 42(7): 565 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Panelli, E. Wang, and F. M. Marincola The Pathway to Biomarker Discovery: Carbonic Anhydrase IX and the Prediction of Immune Responsiveness Clin. Cancer Res., May 15, 2005; 11(10): 3601 - 3603. [Full Text] [PDF] |
||||
![]() |
M. Atkins, M. Regan, D. McDermott, J. Mier, E. Stanbridge, A. Youmans, P. Febbo, M. Upton, M. Lechpammer, and S. Signoretti Carbonic Anhydrase IX Expression Predicts Outcome of Interleukin 2 Therapy for Renal Cancer Clin. Cancer Res., May 15, 2005; 11(10): 3714 - 3721. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. J. Hoogsteen, H. A.M. Marres, K. I.E.M. Wijffels, P. F.J.W. Rijken, J. P.W. Peters, F. J.A. van den Hoogen, E. Oosterwijk, A. J. van der Kogel, and J. H.A.M. Kaanders Colocalization of Carbonic Anhydrase 9 Expression and Cell Proliferation in Human Head and Neck Squamous Cell Carcinoma Clin. Cancer Res., January 1, 2005; 11(1): 97 - 106. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Kim, Z. N. Rabbani, R. T. Vollmer, E.-G. Schreiber, E. Oosterwijk, M. W. Dewhirst, Z. Vujaskovic, and M. J. Kelley Carbonic Anhydrase IX in Early-Stage Non-Small Cell Lung Cancer Clin. Cancer Res., December 1, 2004; 10(23): 7925 - 7933. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bhattacharya, K. Toth, R. Mazurchuk, J. A. Spernyak, H. K. Slocum, L. Pendyala, R. Azrak, S. Cao, F. A. Durrani, and Y. M. Rustum Lack of Microvessels in Well-Differentiated Regions of Human Head and Neck Squamous Cell Carcinoma A253 Associated with Functional Magnetic Resonance Imaging Detectable Hypoxia, Limited Drug Delivery, and Resistance to Irinotecan Therapy Clin. Cancer Res., December 1, 2004; 10(23): 8005 - 8017. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hilvo, M. Rafajova, S. Pastorekova, J. Pastorek, and S. Parkkila Expression of Carbonic Anhydrase IX in Mouse Tissues J. Histochem. Cytochem., October 1, 2004; 52(10): 1313 - 1322. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Kaelin Jr. The Von Hippel-Lindau Tumor Suppressor Gene and Kidney Cancer Clin. Cancer Res., September 15, 2004; 10(18): 6290S - 6295S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Lam, A. S. Belldegrun, and R. A. Figlin Tissue Array-Based Predictions of Pathobiology, Prognosis, and Response to Treatment for Renal Cell Carcinoma Therapy Clin. Cancer Res., September 15, 2004; 10(18): 6304S - 6309S. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Robertson, C. Potter, and A. L. Harris Role of Carbonic Anhydrase IX in Human Tumor Cell Growth, Survival, and Invasion Cancer Res., September 1, 2004; 64(17): 6160 - 6165. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kaluzova, S. Kaluz, M. I. Lerman, and E. J. Stanbridge DNA Damage Is a Prerequisite for p53-Mediated Proteasomal Degradation of HIF-1{alpha} in Hypoxic Cells and Downregulation of the Hypoxia Marker Carbonic Anhydrase IX Mol. Cell. Biol., July 1, 2004; 24(13): 5757 - 5766. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hedley, M. Pintilie, J. Woo, A. Morrison, D. Birle, A. Fyles, M. Milosevic, and R. Hill Carbonic Anhydrase IX Expression, Hypoxia, and Prognosis in Patients with Uterine Cervical Carcinomas Clin. Cancer Res., November 15, 2003; 9(15): 5666 - 5674. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Maxwell HIF-1: An Oxygen Response System with Special Relevance to the Kidney J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2712 - 2722. [Full Text] [PDF] |
||||
![]() |
A. J. Pantuck, G. Zeng, A. S. Belldegrun, and R. A. Figlin Pathobiology, Prognosis, and Targeted Therapy for Renal Cell Carcinoma: Exploiting the Hypoxia-Induced Pathway Clin. Cancer Res., October 15, 2003; 9(13): 4641 - 4652. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zisman, A. J. Pantuck, M. H. T. Bui, J. W. Said, R. R. Caliliw, N. Rao, P. Shintaku, F. Berger, S. S. Gambhir, and A. S. Belldegrun LABAZ1: A Metastatic Tumor Model for Renal Cell Carcinoma Expressing the Carbonic Anhydrase Type 9 Tumor Antigen Cancer Res., August 15, 2003; 63(16): 4952 - 4959. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Hernandez, M. H. T. Bui, K.-r. Han, H. Mukouyama, D. G. Freitas, D. Nguyen, R. Caliliw, P. I. Shintaku, S. H. Paik, C.-L. Tso, et al. Novel Kidney Cancer Immunotherapy Based on the Granulocyte- Macrophage Colony-stimulating Factor and Carbonic Anhydrase IX Fusion Gene Clin. Cancer Res., May 1, 2003; 9(5): 1906 - 1916. [Abstract] [Full Text] [PDF] |
||||
![]() |
S-Y Liao, S Ivanov, A Ivanova, S Ghosh, M A Cote, K Keefe, M Coca-Prados, E J Stanbridge, and M I Lerman Expression of cell surface transmembrane carbonic anhydrase genes CA9 and CA12 in the human eye: overexpression of CA12 (CAXII) in glaucoma J. Med. Genet., April 1, 2003; 40(4): 257 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kaluz, M. Kaluzova, and E. J. Stanbridge Expression of the Hypoxia Marker Carbonic Anhydrase IX Is Critically Dependent on SP1 Activity. Identification of a Novel Type of Hypoxia-responsive Enhancer Cancer Res., March 1, 2003; 63(5): 917 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. T. Bui, D. Seligson, K.-r. Han, A. J. Pantuck, F. J. Dorey, Y. Huang, S. Horvath, B. C. Leibovich, S. Chopra, S.-Y. Liao, et al. Carbonic Anhydrase IX Is an Independent Predictor of Survival in Advanced Renal Clear Cell Carcinoma: Implications for Prognosis and Therapy Clin. Cancer Res., February 1, 2003; 9(2): 802 - 811. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. A. M. Kaanders, K. I. E. M. Wijffels, H. A. M. Marres, A. S. E. Ljungkvist, L. A. M. Pop, F. J. A. van den Hoogen, P. C. M. de Wilde, J. Bussink, J. A. Raleigh, and A. J. van der Kogel Pimonidazole Binding and Tumor Vascularity Predict for Treatment Outcome in Head and Neck Cancer Cancer Res., December 1, 2002; 62(23): 7066 - 7074. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bodmer, W. van den Hurk, J. J. M. van Groningen, M. J. Eleveld, G. J. M. Martens, M. A. J. Weterman, and A. Geurts van Kessel Understanding familial and non-familial renal cell cancer Hum. Mol. Genet., October 1, 2002; 11(20): 2489 - 2498. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kaluz, M. Kaluzova, A. Chrastina, P. L. Olive, S. Pastorekova, J. Pastorek, M. I. Lerman, and E. J. Stanbridge Lowered Oxygen Tension Induces Expression of the Hypoxia Marker MN/Carbonic Anhydrase IX in the Absence of Hypoxia-inducible Factor 1{alpha} Stabilization: A Role for Phosphatidylinositol 3'-Kinase Cancer Res., August 1, 2002; 62(15): 4469 - 4477. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. Hui, A. T. C. Chan, F. Pezzella, H. Turley, K.-F. To, T. C. W. Poon, B. Zee, F. Mo, P. M. L. Teo, D. P. Huang, et al. Coexpression of Hypoxia-inducible Factors 1{alpha} and 2{alpha}, Carbonic Anhydrase IX, and Vascular Endothelial Growth Factor in Nasopharyngeal Carcinoma and Relationship to Survival Clin. Cancer Res., August 1, 2002; 8(8): 2595 - 2604. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Leppilampi, P. Koistinen, E.-R. Savolainen, J. Hannuksela, A.-K. Parkkila, O. Niemela, S. Pastorekova, J. Pastorek, A. Waheed, W. S. Sly, et al. The Expression of Carbonic Anhydrase II in Hematological Malignancies Clin. Cancer Res., July 1, 2002; 8(7): 2240 - 2245. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Olive, C. Aquino-Parsons, S. H. MacPhail, S.-Y. Liao, J. A. Raleigh, M. I. Lerman, and E. J. Stanbridge Carbonic Anhydrase 9 as an Endogenous Marker for Hypoxic Cells in Cervical Cancer Cancer Res., December 1, 2001; 61(24): 8924 - 8929. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gruvberger, M. Ringner, Y. Chen, S. Panavally, L. H. Saal, A. Borg, M. Ferno, C. Peterson, and P. S. Meltzer Estrogen Receptor Status in Breast Cancer Is Associated with Remarkably Distinct Gene Expression Patterns Cancer Res., August 1, 2001; 61(16): 5979 - 5984. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Ivanova, S. V. Ivanov, A. Danilkovitch-Miagkova, and M. I. Lerman Regulation of STRA13 by the von Hippel-Lindau Tumor Suppressor Protein, Hypoxia, and the UBC9/Ubiquitin Proteasome Degradation Pathway J. Biol. Chem., April 27, 2001; 276(18): 15306 - 15315. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |